Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review

D Mozaffarian - Circulation, 2016 - Am Heart Assoc
Suboptimal nutrition is a leading cause of poor health. Nutrition and policy science have
advanced rapidly, creating confusion yet also providing powerful opportunities to reduce the …

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

AFG Cicero, A Colletti, G Bajraktari… - Nutrition …, 2017 - academic.oup.com
In recent years, there has been growing interest in the possible use of nutraceuticals to
improve and optimize dyslipidemia control and therapy. Based on the data from available …

Coffee and tea on cardiovascular disease (CVD) prevention

D Chieng, PM Kistler - Trends in cardiovascular medicine, 2022 - Elsevier
Coffee and tea are amongst the most consumed beverages worldwide, and are the main
source of caffeine in adults. In this review we present findings on the effects of habitual …

The role of nutraceuticals in statin intolerant patients

M Banach, AM Patti, RV Giglio, AFG Cicero… - Journal of the American …, 2018 - jacc.org
Statins are the most common drugs administered for patients with cardiovascular disease.
However, due to statin-associated muscle symptoms, adherence to statin therapy is …

[HTML][HTML] The 2015 Dutch food-based dietary guidelines

D Kromhout, CJK Spaaij, J de Goede… - European journal of …, 2016 - nature.com
The objective of this study was to derive food-based dietary guidelines for the Dutch
population. The dietary guidelines are based on 29 systematic reviews of English language …

[HTML][HTML] Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?

AFG Cicero, F Fogacci, AP Stoian, M Vrablik… - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …

Antioxidants from black and green tea: From dietary modulation of oxidative stress to pharmacological mechanisms

I Peluso, M Serafini - British journal of pharmacology, 2017 - Wiley Online Library
The consumption of tea (Camellia sinensis) has been correlated with a low incidence of
chronic pathologies, such as cardiovascular disease and cancer, in which oxidative stress …

Effects of polyphenol intake on metabolic syndrome: current evidences from human trials

G Chiva-Blanch, L Badimon - Oxidative medicine and cellular …, 2017 - Wiley Online Library
Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors which severely
increases the risk of type II diabetes and cardiovascular disease. Several epidemiological …

Functional foods and dietary supplements for the management of dyslipidaemia

PM Hunter, RA Hegele - Nature Reviews Endocrinology, 2017 - nature.com
Dyslipidaemia is characterized by increased blood levels of total or LDL cholesterol and
triglycerides, or decreased HDL cholesterol levels, and is a risk factor for cardiovascular …

[HTML][HTML] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023 - Elsevier
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …